If you really want to call yourself a counter investor, it’s time to take a closer look at what hasn’t worked so far this year: value stocks and dividend stocks. Value stocks have underperformed growth stocks (especially Tesla Inc. TSLA, -4.09% and the most popular tech names) amid the economic …
Read More »Abbott, J&J results were fueled by June’s surprising surge in medical procedures, even as coronavirus cases rise
Abbott Laboratories and Johnson & Johnson separately reported recoveries from elective procedures earlier than expected in US hospitals in the second quarter, even as the nation struggles with an increasingly severe COVID-19 pandemic. Shares of Abbott ABT, + 2.95% closed at a year-to-date high of $ 99.25, the day after …
Read More »